CD34

Description

CD34 antibody antigen is selectively expressed in human lymphoid and myeloid hematopoietic progenitor cells. Studies have shown the CD34 antibody also reacts with vascular endothelial cells in normal tissues and in benign and malignant proliferations. The utility of CD34 is in the study of benign and malignant vascular tumors as well as characterization of acute leukemia in bone marrow. CD34 has been used to measure angiogenesis in many types of tumors, which reportedly predicts tumor recurrence. It is also useful to aid the differentiation of dermatofibrosarcoma protuberans from fibrous histiocytoma.

SPECIFICATIONS

Specifications

INTENDED USE IVD
SPECIES REACTIVITY Human
SOURCE Mouse Monoclonal
CLONE QBEnd/10
ISOTYPE IgG1
ANTIGEN CD34
LOCALIZATION Cell Surface and cytoplasmic
POSITIVE CONTROL Tonsil, skin or angiosarcom
DATASHEETS & SDS
Download Data Sheet
Download RUO Data Sheet
Download SDS Sheet

Regulatory Notice: Biocare’s IVD-labeled products comply with US-FDA and European IVDD regulation. Other regions may have additional requirements for such labeling, please contact your local distributor.

REFERENCES

1. Mikalsen LT, et al. Anticancer Res. 2011 Dec; 31(12):4053-60.
2. Kong Y, et al. Leukemia. 2008 Jun; 22(6):1207-13.
3. Li N, et al. Am J Dermatopathol. 2004 Aug; 26(4):267-72.

Reviews

There are no reviews yet.

Be the first to review “CD34”

Your email address will not be published. Required fields are marked *